Table 3.

Distribution of molecular results in resected tissues and nodules aspirates

	Resected tissues (n = 240)				Nodule aspirates (n = 235)
	Malignant (n = 130)		Benign (n = 110)		Malignant (n = 93)		Benign (n = 142)
	HR/Pos	LR/Neg	HR/Pos	LR/Neg	HR/Pos	LR/Neg	HR/Pos	LR/Neg
miRNA classifier A	81	49	7	103	71	22	12	130
miRNA classifier B	118	12	46	64	87	6	42	100
17‐mutation panel	71	59	15	95	65	28	10	132
Mutation + classifier A	97	33	18	92	78	15	15	127
Mutation + classifier B	122	8	51	59	88	5	45	97

HR/Pos, high risk by miRNA testing or positive by mutation testing; LR/Neg, low risk by miRNA testing or negative by mutation testing (negative by both tests for combined testing).